[Finished Printing? - Click Here to Return to Normal View]


NIDA Home > Researchers and Health Professionals > Past Meetings Summaries    

Drug Use Trajectories Among African-Americans



Bethesda North Marriott Hotel Conference Center
Bethesda, MD
November 13, 2006

NIDA Organizer:
Yonette Thomas, Ph.D.

Meeting Purpose and Intent:

The purpose of this workshop was to:

  • Provide an opportunity for researchers from different disciplines to highlight and answer epidemiologic questions related to drug abuse trajectories among African Americans and
  • Engage participants in a focused discussion on how to critically generate prevention interventions that are likely to best serve this population.

Questions to be addressed include the following:

  • What do we mean by "drug abuse trajectory?"
  • What does the current literature say about drug abuse trajectories and how they differ by race/ethnicity?
  • What risk and protective factors are related to the different trajectories and crossover effects and do these factors differ across and within racial/ethnic groups and among African Americans in particular?
  • What gaps exist in our research in understanding trajectories of drug abuse among African Americans?
  • How do trajectories link to high-risk outcomes such as HIV/AIDS?
  • What should the next generation of research look like particularly with regard to prevention interventions?
  • How can NIDA encourage research to address these questions?

Brief Discussion of Meeting Outcome:

Various topics were raised in the discussion, such as:

  • Discrimination
  • Are current research methods and tools adequate for measuring such factors as discrimination and incarceration?
  • Stress - Do the data imply that African-Americans are exposed to more stress? The general conclusion was that the fundamental question is: "why they don't use drugs much more, given the stressors and what are the coping mechanisms that help explain that?"
  • Is the research community fully exploiting the data that already exist?
  • Are there ways to reexamine existing data to address some of the gaps in knowledge?
  • To what extent are new studies needed, and what approach should they take?

Participants discussed various ways of publishing the information shared at the meeting, such as in a special issue of a journal and the contents and parameters of that publication. They agreed to continue the discussion in a follow-up conference call.

Publications: None to date

Participant list (PDF Format, 176kb), (Word Format, 248kb)
Agenda (PDF Format, 188kb), (Word Format, 148kb)


What's New Contents



NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment



National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Wednesday, July 23, 2008. The U.S. government's official web portal